GOALS AND OBJECTIVES BREAST PATHOLOGY

Similar documents
GOALS AND OBJECTIVES FOR THORACIC PATHOLOGY ROTATION

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

GOALS AND OBJECTIVES CYTOPATHOLOGY

RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES

Goals and Objectives for Cytopathology Rotation

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

Minimizing Errors in Diagnostic Pathology

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

PATHOLOGY FELLOWSHIP PROGRAM IN LYMPHOPROLIFERATIVE DISORDERS

CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY

Quality Assurance and Quality Control in the Pathology Dept.

Gynecologic Oncology Level: PGY-4

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Basement membrane in lobule.

Barriers to Understanding

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

Papillary Lesions of the Breast

ANATOMICAL PATHOLOGY TARIFF

GYNECOLOGICAL PATHOLOGY FELLOWSHIP PROGRAM

ACRIN 6666 Therapeutic Surgery Form

Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy

Proliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Saima Saeed MD

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

Quality assurance and quality control in pathology in breast disease centers

Reporting of Breast Cancer Do s and Don ts

Case study 1. Rie Horii, M.D., Ph.D. Division of Pathology Cancer Institute Hospital, Japanese Foundation for Cancer Research

Introduction 1. Executive Summary 5

Flat Epithelial Atypia

MBP AP 3 Core Curriculum

Breast Cancer Diagnosis, Treatment and Follow-up

Ductal Carcinoma-in-Situ: New Concepts and Controversies

Image guided core biopsies:

BreastScreen Victoria Annual Statistical Report

3/27/2017. Disclosure of Relevant Financial Relationships. Papilloma???

Breast Cancer Pathway Map

Breast Cancer. Dr. Andres Wiernik 2017

Handout for Dr Allison s Lectures on Grossing Breast Specimens:

Guven Hospital - Ankara, Turkey

ESSO ACCREDITED TRAINING FELLOWSHIP IN BREAST SURGERY

Gastrointestinal PATHOLOGY FELLOWSHIP

DIAGNOSIS. Biopsy, Pathology and Subtypes. Knowledge Summary

Breast Cancer Staging

Jessa Hospital - Hasselt, Belgium

Groote Schuur Academic Hospital - Cape Town, South Africa

BREAST PATHOLOGY GROSSING GUIDELINES

Alexandrovska Hospital - Sofia, Bulgaria

Adequate Core Biopsy Samples from Stereotactic Biopsies Needed for Today s Breast Pathology

Papillary Lesions of the Breast

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives

Breast Cancer MultiDisciplinary Approach

SCOPE OF PRACTICE PGY-4 PGY-5

Pathology Report Patient Companion Guide

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

Invasive Papillary Breast Carcinoma

A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues

Classification System

Table of contents. Page 2 of 40

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

National Center of Oncology - Yerevan, Armenia

BreastScreen Victoria Annual Statistical Report

BreastScreen Aotearoa Annual Report 2015

Breast Unit - University of Heidelberg - Heidelberg, Germany

Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

American Journal of Cancer Case Reports. Invasive Papillary Carcinoma of Male Breast: A Rare Case Report

BreastScreen Victoria Annual Statistical Report

Mucinous breast cancer

Mamma Centrum / Zelený Pruh - Prague, Czech Republic

My Personalized Breast Cancer Worksheet

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer

Proliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Breast Cancer Diversity Various Disease Subtypes Clinical Diversity

Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Goals & Objectives CanMeds VGH Neuroradiology MRI VGH 899 West 12th Ave., Vancouver, BC V5Z 1M9

National Breast Cancer Audit next steps. Martin Lee

Tata Memorial Hospital - Mumbai, India

The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening.

HOSPITAL MODELO - LA CORUÑA, Spain

Breast cancer staging update. Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Cork University Hospital - Cork, Ireland

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

57th Annual HSCP Spring Symposium 4/16/2016

San Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy

Health Sciences Centre, Team A, Dr. L. Bohacek (Endocrine Surgery) Medical Expert

Surgical Pathology Issues of Practical Importance

Pathology Student Interest Group. Sponsored by the College of American Pathologists

Hospital Universitari La Fe - Valencia, Spain

Pathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY

BreastScreen Victoria Annual Statistical Report

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina

Urology Case Conference (a.k.a. Pyelogram, IVP) Time/Location: 2nd Monday of every month at 07:00 08:30

Transcription:

GOALS AND OBJECTIVES BREAST PATHOLOGY LEVEL: PGY2, PGY3, PGY5 A number of these rotations are introductory in nature, as they are major subspecialties, and are followed by two more blocks in PGY-3, during which knowledge is extended and fortified. As described above, the staff pathologist is expected to provide an appropriate volume of cases for review based on the PGY-2 resident s level of training in these areas with the understanding that greater responsibility and workload will be taken on in PGY-3. Additionally, while PGY-2 residents are expected to be present at all interdisciplinary rounds in these major subspecialties, they are not expected to present cases while a more senior resident is on service. Staff pathologists are required to be present at all interdisciplinary rounds during which a resident is presenting, particularly for PGY2. During the PGY-3 year, while completing the 2-block rotations in the major areas of subspecialty, the resident is expected to prepare for and present cases at all interdisciplinary rounds, and, with staff pathologist supervision and guidance, answer questions and take part in discussion during said rounds. Furthermore, the PGY-3 resident is expected to complete any end-of-rotation presentations required for the major subspecialty rotations during this year. The PGY-5 year is one of senior leadership and the resident should be able to assume responsibility for organizing the service and supervising junior residents and students. The resident should have mastery of the information contained in standard texts and be prompt in using the literature to solve specific problems. The resident will be responsible for presentations at conferences and for teaching junior residents and students on a routine basis. The PGY 5 should begin to have an understanding of the role of the practitioner in an integrated health care delivery system and to be aware of the issues in health care management facing patients and physicians.

MEDICAL EXPERT Demonstrate a working knowledge of the anatomy and histology of the breast Demonstrate skill in the gross dissection and sampling of breast biopsies, breast excisions including needle localized specimens, mastectomies, lymph node dissections and sentinel node biopsies Demonstrate ability to deal with difficult gross specimens i.e. specimens requiring further x- ray, occult tumors, poorly oriented specimens Demonstrate proficiency in the interpretation of breast needle core biopsies, and knowledge of lesions that cannot be adequately assessed in a limited biopsy sample Acquire proficiency in the interpretation of breast excisions and ability to prepare accurate comprehensive reports Acquire knowledge of the spectrum of benign breast lesions including atypical hyperplasia, and the associated risk implications Acquire knowledge of clinically important prognostic/predictive factors for invasive and in situ breast carcinoma Acquire knowledge in the use and interpretation of immunohistochemistry pertinent to breast pathology, including hormone receptors, Her2/neu markers and myoepithelial markers. Acquire knowledge in the use and interpretation of Her2/neu FISH for invasive breast cancer Acquire knowledge of the spectrum of stromal breast lesions COMMUNICATOR/COLLABORATOR Demonstrate the ability to function at a junior staff pathologist level at breast tumor rounds by reviewing cases, presenting the cases at rounds and responding to questions regarding the cases Demonstrate the ability to teach aspects of breast pathology at multidisciplinary rounds and teaching sessions Gain an understanding of clinical aspects of breast disease, particularly in breast tumor board

MANAGER Understand the importance of quality control and quality assurance measures for ER, PR and Her2/neu immunohistochemistry for breast cancer, including preanalytical, analytical and postanalytical variables Understand the value of proficiency testing for immunohistochemistry. HEALTH ADVOCATE/PROFESSIONAL Understand the importance of turn-around time for diagnostic breast biopsies due to the high level of stress experienced by patients with symptomatic or screen detected breast lesions Understand the implications of a diagnosis of invasive or in situ breast carcinoma for patients Know when to appropriately consult an expert in breast pathology Know the clinical significance of benign and atypical proliferative breast lesions and the associated risk implications SCHOLAR Consider conducting a research project or case report based on breast pathology material Review the pertinent literature relating to advances in breast pathology (i.e. sentinel lymph node assessment, hormone receptor IHC, Her2/neu testing, columnar lesions, molecular profiling of breast tumors) INSTRUCTIONAL TOOLS: The resident will meet with the subspecialty group director and go over this document and the overall aspects of the rotation the day before the rotation starts. 1. GROSSING: - At least two cases per week - The resident should gross at least the following specimen types: PGY2 level: Three total mastectomies Three lumpectomies Two core needle biopsies Two vacuum assisted biopsies

At least one case of post neo-adjuvant At least one case of DCIS with mapping PGY3-5 level: Three total mastectomies Three lumpectomies Two breast reductions - Resident will complete a grossing log (see table at the end). The resident will review the slides of the case that he/she grossed and review it with the attending pathologist assigned to the case. The attending will review the gross description and sign the log sheet. 2. MICROSCOPY: - The resident will contact the attending pathologist that is scheduled to sign cases with, the day before the sign out day, in order to arrange time of sign out and distribute cases - Retrieve pertinent clinical and radiologic information from the electronic medical records system for every case and integrate it with the pathologic findings in order to achieve a correct diagnosis. 3. PROGNOSTIC MARKERS: learn how to properly interpret immunohistochemistry for breast prognostic markers ER, PR, HER2Neu - learn indicators for F(ISH) - learn how to interpret F(ISH) 4. ROUNDS: PGY2 level: Resident is expected to attend but not present at interdisciplinary rounds (on Mondays at 12:00 pm if possible since conflicts with academic day, and on Tuesdays at 8:00 am) and the consensus conference (on Fridays at 10:00 am) PGY 3-4: Resident is expected to attend interdisciplinary and consensus conferences and present the cases. This implies reviewing the cases with the pathologist in charge beforehand and organizing the presentation in the appropriate format. 5. EVALUATION: The resident will be given an evaluation based on the objectives and PGY level milestones and practical examination at the end of the rotation. RECOMMENDED READING:

1. Sternberg s Diagnostic Surgical pathology 2. Rosen s Breast Pathology 3. BIOPSY INTERPRETATION OF THE BREAST by Stuart Schnitt and Laura C. Collins 4. Travassolli: Pathology of the Breast 5. WHO Classification of Tumours of the Breast 2012. 6. Diagnostic pathology Breast, By Hicks and Lester. Amyrsis and LWW. 2012.

Table. Grossing log Resident Rotation Dates DATE CASE NUMBER CASE TYPE CASE REVIEWED BY (PATHOLOGIST NAME AND SIGNATURE) Total mastectomy Total mastectomy Total mastectomy Lumpectomy Lumpectomy Lumpectomy Vacuum assisted Bx Breast reduction Breast reduction Core needle Bx Revised April 2016